The Business Research Company’s report on the Transfection Reagents And Equipment Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the transfection reagents and equipment industry?
The rising number of cancer patients worldwide is expected to propel the growth of the transfection reagents and equipment market going forward. Cancer is a group of diseases in which cells grow abnormally and uncontrollably. Transfection reagents are commonly used in cancer research to introduce foreign genetic material, such as plasmid DNA or RNA molecules, and allow researchers to investigate various aspects of cancer biology, such as gene expression studies, gene silencing, drug screening, and target validation. For instance, in April 2024, the American Cancer Society, a US-based non-profit organization, reported 20 million new cancer cases and 9.7 million deaths in 2022. Therefore, the rising number of cancer patients worldwide drives the growth of the transfection reagents and equipment market.
Access Your Free Sample of the Global Transfection Reagents And Equipment Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10780&type=smp
What is the estimated market size of the transfection reagents and equipment sector by 2029, based on current forecasts?
The transfection reagents and equipment market size has grown rapidly in recent years. It will grow from$1.58 billion in 2024 to $1.75 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to biomedical research demand, pharmaceutical development, rise in biotechnology applications, academic and research institutions, genetic engineering advancements
The transfection reagents and equipment market size is expected to see rapid growth in the next few years. It will grow to “$2.69 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to gene therapy advancements, increasing bioproduction needs, emerging cell-based therapies, r&d in personalized medicine, global collaborations. Major trends in the forecast period include focus on primary cell transfection, shift towards electroporation techniques, integration of nanotechnology in transfection, increasing demand for animal-free transfection reagents, automation and high-throughput transfection systems.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10780&type=smp
#Who are the top players in the transfection reagents and equipment market?
Major companies operating in the transfection reagents and equipment market include Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., Maxcyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., PromoCell GmbH, PerkinElmer Inc., Agilent Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Sartorius AG, Takara Bio Inc., Tecan Trading AG, Polyplus-transfection SA, Sigma-Aldrich Corporation, Hoffmann-La Roche Ltd., Transfection Technologies Inc., Viromer, ABM Inc., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc., chemicell GmbH, Genlantis, Biontex Laboratories GmbH, Boca Scientific Inc., Jena Bioscience GmbH
#What are the major trends in the transfection reagents and equipment market?
Product innovation is a key trend gaining popularity in the transfection reagents and equipment market. Major companies operating in the transfection reagents and equipment market are focusing on developing innovative products to sustain their position in the market. For instance, in September 2022, Polyplus-Transfection SA, a France-based biotechnology company, launched an in vivo-jetRNA+ transfection reagent for in vivo mRNA delivery using a preformed liposome formulation. This innovative product is a highly efficient and scalable gene delivery system that can deliver mRNA to various tissues and cell types. The reagent is also safe and well-tolerated, making it a promising option for developing new gene therapies. The ready-to-use structure avoids the need for formulation stages, and the stable liposome size allows for mRNA concentrations ranging from low to high over time. Prophylactic vaccinations, mRNA treatments (cancer therapy, uncommon diseases, others), and gene editing are examples of applications.
Which geography holds the highest transfection reagents and equipment market share?
North America was the largest region in the transfection reagents and equipment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
How do different segments contribute to the overall expansion of the transfection reagents and equipment market?
The transfection reagents and equipment market covered in this report is segmented –
1) By Products: Instruments, Reagent And Kits
2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules
3) By Organism: Bacteria, Mammalian Cells, Fungi, Plants, Virus
4) By End User: Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs) And Contract Development And Manufacturing Organizations (CDMOs), Academia, Hospitals, Clinical Labs, Other End Users
Subsegments:
1) By Instruments: Electroporation Systems, Microinjection Systems, Particle Bombardment Systems, Other Instruments
2) By Reagent And Kits: Lipid-Based Transfection Reagents, Polymer-Based Transfection Reagents, Protein-Based Transfection Reagents, Nucleic Acid Delivery Kits, Other Reagents And Kits
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10780
How is the transfection reagents and equipment market defined?
Transfection reagents refer to substances or kits used to introduce foreign genetic material, such as DNA or RNA, into cells. These reagents facilitate the delivery of nucleic acids into cells, allowing researchers to study gene expression, manipulate gene function, or produce recombinant proteins.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
